How much does lorlatinib/lorlatinib cost per month of treatment?

Lorlatinib/ Lorlatinib ( Lorlatinib) is a targeted drug used to treat ALK-positive metastatic non-small cell lung cancer. Because of its higher selectivity and wider mutation coverage, it is regarded as an important back-line treatment option in many countries around the world. One of the questions that patients are most concerned about when choosing lorlatinib treatment is how much it will cost per month. Due to the different pricing systems, medical insurance coverage, and whether to choose original drugs or generic drugs in different countries, the monthly cost differences are very obvious. Therefore, understanding the price structure can help patients develop a more reasonable treatment budget.

In the domestic market, the original drug of lorlatinib has been officially launched and has entered the Category B medical insurance reimbursement directory under the name of "lorlatinib tablets". Its common specifications are 25mg×90 tablets and 100mg×30 tablets, which meet the recommended dosage of “100mg once a day”. The price of a single box without medical insurance reimbursement is about 20,000 yuan. In some areas, patients can significantly reduce the actual out-of-pocket amount through medical insurance. The inclusion in the medical insurance directory has greatly improved accessibility, allowing more patients to maintain targeted therapy in the long term.

In addition to original drugs, some generic versions of relatively stable quality drugs have also appeared on the market, which are an alternative option for patients with heavy financial burdens or who require long-term treatment. For example, taking the 100 mg × 30 tablets produced by a Lao pharmaceutical factory as an example, the price may be only about one thousand yuan, which has obvious cost advantages. The active ingredients of such products are consistent with the original drugs, but patients should still ensure that the drug purchase channels are formal to ensure the quality and stability of the drugs.

In general, the cost of one month's treatment with lorlatinib ranges from 1,000 yuan to 50,000 yuan depending on the version. The core factors that affect the cost include: whether it is an original drug, whether it is included in medical insurance, the country and channel of purchase, and exchange rate changes during the same period.

Reference materials：https://www.lorbrena.com/